CMH — Chordate Medical Holding AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK0.95m
- -SEK3.30m
- SEK0.66m
Brief: Chordate Medical Launches Pre-Study For FDA Market Approval In U.S
Brief: Chordate To Change Trading Venue To Nasdaq First North Growth Market
Brief: Chordate Medical Q2 Operating Loss Widens To SEK 5.1 Mln
Brief: Chordate Medical Receives Order Worth SEK 167,000
Brief: Chordate: Clinical Evaluation Of Treatment For Rhinitis In Public Hospitals In Saudi Arabia Now Approved
Brief: Chordate Via Italian Vedise Hospital Gets Order Worth About SEK 125,000
Brief: Chordate Q1 Pretax Loss Widens To Sek 5.8 Mln
Brief: Chordate Medical Holding: Patient Study On Chronic Migraine Resumed In Germany
Brief: Chordate Medical Gets CE marking For K.O.S Method Against Chronic Migraine
Brief: Chordate: Hawoc Investment Increases Stake In Co To About 10.4%
Brief: Chordate Q4 Pretax Loss Narrows To SEK 5.6 Million
Brief: Chordate Medical Holding Resumes Finnish Study Of Chronical Migraine
Brief: Chordate: Isac Brandberg Raises Stake In Co
Brief: Chordate Treatment Tested For Chronic Rinitis In Public Hospitals In Saudi Arabia
Brief: Chordate Medical Holding Q3 Operating Loss Narrows To SEK 4.0 Million
Brief: Chordate's Study On Chronic Migraine To Resume Patient Recruitment
Brief: Chordate Medical Holding Has CE-Marked Newly Developed Control Unit
Brief: Chordate Medical Holding Announces Outcome Of Rights Issue
Brief: Chordate Medical Extends Subscription Period In Ongoing Directed Issue Until Sept 4